HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chaosu Hu Selected Research

taxane

8/2022Taxane/gemcitabine-containing chemotherapy plus locoregional IMRT for patients with de novo metastatic nasopharyngeal carcinoma: the treatment outcomes and prognostic factors analysis.
12/2013Neoadjuvant chemotherapy followed by concurrent chemoradiation for locoregionally advanced nasopharyngeal carcinoma: interim results from 2 prospective phase 2 clinical trials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Chaosu Hu Research Topics

Disease

80Nasopharyngeal Carcinoma
04/2024 - 09/2006
32Neoplasms (Cancer)
12/2023 - 09/2006
26Neoplasm Metastasis (Metastasis)
11/2023 - 05/2006
7Nasopharyngeal Neoplasms (Cancer of the Nasopharynx)
12/2023 - 04/2011
7Carcinoma (Carcinomatosis)
10/2023 - 12/2016
6Squamous Cell Carcinoma of Head and Neck
01/2024 - 01/2018
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021 - 03/2009
5Xerostomia
12/2019 - 07/2012
5Mucositis
12/2018 - 06/2013
4Necrosis
03/2019 - 03/2011
3Inflammation (Inflammations)
01/2023 - 01/2018
3Neutropenia
07/2021 - 06/2013
3Head and Neck Neoplasms (Head and Neck Cancer)
01/2021 - 11/2018
2Deglutition Disorders (Dysphagia)
01/2024 - 01/2021
2Mucoepidermoid Carcinoma
08/2023 - 11/2020
2Lymphatic Metastasis
01/2021 - 10/2018
2Aggressive Fibromatosis (Desmoid)
11/2019 - 01/2019
2Cranial Nerve Diseases (Cranial Nerve Disorders)
12/2018 - 04/2011
2Weight Loss (Weight Reduction)
11/2018 - 01/2018
2Stomatitis
09/2017 - 06/2013
2Leukopenia
09/2015 - 06/2013
1Disease Progression
11/2023
1Hypoxia (Hypoxemia)
11/2023
1Hypopharyngeal Neoplasms
11/2023
1Oropharyngeal Neoplasms
01/2023
1Salivary Gland Neoplasms (Salivary Gland Cancer)
11/2022
1Hypothyroidism
03/2022
1Adenocarcinoma of Lung
01/2022
1Cardiac Arrhythmias (Arrythmia)
01/2021
1Multiple Organ Failure (MODS)
01/2021
1Respiratory Insufficiency (Respiratory Failure)
01/2021
1Rupture
01/2021
1COVID-19
01/2020
1Chondrosarcoma
11/2019
1Chordoma
11/2019
1Hearing Loss (Hearing Impairment)
12/2018
1Body Weight (Weight, Body)
11/2018
1Ulcer
01/2018
1Unknown Primary Neoplasms
06/2017
1Thyroid Neoplasms (Thyroid Cancer)
02/2017
1Pathologic Processes
01/2017
1Breast Neoplasms (Breast Cancer)
09/2016

Drug/Important Bio-Agent (IBA)

15Cisplatin (Platino)FDA LinkGeneric
11/2023 - 03/2012
8GemcitabineFDA Link
11/2023 - 03/2012
6Fluorouracil (Carac)FDA LinkGeneric
07/2020 - 06/2013
5Docetaxel (Taxotere)FDA Link
07/2021 - 06/2013
4toripalimabIBA
11/2023 - 01/2021
4L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
11/2023 - 01/2018
3DNA (Deoxyribonucleic Acid)IBA
03/2023 - 01/2017
3Biomarkers (Surrogate Marker)IBA
01/2019 - 01/2018
2ErbB Receptors (EGF Receptor)IBA
01/2024 - 09/2016
23-nitrophenyl 3-piperidinecarboxylate (MNPC)IBA
02/2023 - 08/2022
2taxaneIBA
08/2022 - 12/2013
2PlatinumIBA
01/2021 - 06/2017
2Proteins (Proteins, Gene)FDA Link
01/2020 - 11/2018
2salicylhydroxamic acid (SHAM)IBA
12/2019 - 07/2012
2Cetuximab (Erbitux)FDA Link
01/2016 - 06/2013
1Monoclonal AntibodiesIBA
01/2024
1nitazoxanide (NTZ)FDA Link
01/2024
1nimotuzumabIBA
01/2024
1Programmed Cell Death 1 ReceptorIBA
01/2024
1tislelizumabIBA
12/2023
1Immune Checkpoint InhibitorsIBA
11/2023
1RNA (Ribonucleic Acid)IBA
11/2023
1methyl alpha- D- 6- (12- (9- anthroyl)stearoyl)glucosideIBA
08/2023
1GoldIBA
11/2022
1Thyroid HormonesIBA
03/2022
1camrelizumabIBA
01/2021
1avelumabIBA
01/2021
1Therapeutic UsesIBA
01/2021
1Sodium Glutamate (Accent)IBA
11/2020
1Protons (Proton)IBA
11/2019
1Bevacizumab (Avastin)FDA Link
10/2019
1Immunoglobulin A (IgA)IBA
01/2019
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019
1N(4)-chloroacetylcytosine arabinoside (CACA)IBA
01/2018
1Hemoglobins (Hemoglobin)IBA
01/2018
1Serum AlbuminIBA
01/2018
1CarbonIBA
01/2018
1Messenger RNA (mRNA)IBA
09/2017
1prolinedithiocarbamate (PDTC)IBA
02/2017
1GSK-2816126IBA
01/2017
1Enhancer of Zeste Homolog 2 ProteinIBA
01/2017
1Trastuzumab (Herceptin)FDA Link
09/2016

Therapy/Procedure

63Radiotherapy
04/2024 - 05/2006
40Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
04/2024 - 01/2010
36Drug Therapy (Chemotherapy)
02/2024 - 05/2006
15Chemoradiotherapy
02/2024 - 03/2008
14Induction Chemotherapy
01/2024 - 03/2008
13Therapeutics
11/2023 - 04/2014
6Neoadjuvant Therapy
07/2021 - 03/2012
4Re-Irradiation
11/2023 - 09/2006
3Adjuvant Chemotherapy
12/2021 - 04/2016
2Heavy Ion Radiotherapy
04/2024 - 11/2019
2Salvage Therapy
01/2018 - 01/2018
2Conformal Radiotherapy
01/2013 - 09/2006
1Adjuvant Chemoradiotherapy
03/2023
1Intravenous Injections
11/2022
1Lymph Node Excision (Lymph Node Dissection)
01/2021
1Tracheotomy
02/2017